FDA Authorizes Convalescent Plasma as Potential COVID-19 Treatment
October 23, 2020
No Comments
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients